Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L B Sheiner

Showing results (81-90 of 142) with videos related to

Pageof 15
Sort By:
Clinical Pharmacology and Therapeutics|September 1, 1979
Forecasting individual pharmacokineticsL B Sheiner, S Beal, B Rosenberg, et al.
Journal of Pharmacokinetics and Biopharmaceutics|June 1, 1996
Do we need full compliance data for population pharmacokinetic analysis?P Girard, L B Sheiner, H Kastrissios, et al.
Journal of Pharmacokinetics and Biopharmaceutics|December 1, 1977
The clinical pharmacokinetics of phenytoinE Martin, T N Tozer, L B Sheiner, et al.
Journal of Pharmacokinetics and Biopharmaceutics|July 29, 1998
A semiparametric method for describing noisy population pharmacokinetic dataK Park, D Verotta, T F Blaschke, et al.
British Medical Journal|October 20, 1973
Pharmacokinetics of digoxin: interpreting bioavailabilityN Sanchez, L B Sheiner, H Halkin, et al.
Statistics in Medicine|November 20, 1998
A Markov mixed effect regression model for drug complianceP Girard, T F Blaschke, H Kastrissios, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 27, 2001
Selecting reliable pharmacokinetic data for explanatory analyses of clinical trials in the presence of possible noncomplianceJ Lu, J M Gries, D Verotta, et al.
Journal of Clinical Epidemiology|January 1, 1991
Laboratory data predicts survival post hospitalizationL B Sheiner, M J Easterling, B Mozes, et al.
Clinical Pharmacology and Therapeutics|March 1, 1974
Differences in serum digoxin concentrations between outpatients and inpatients: an effect of compliance?L B Sheiner, B Rosenberg, V V Marathe, et al.
Clinical Pharmacology and Therapeutics|January 1, 1976
The renal elimination of procainamideR L Galeazzi, L B Sheiner, T Lockwood, et al.
Pageof 15

Showing results (81-90 of 142) with videos related to

Sort By:
Pageof 15
Clinical Pharmacology and Therapeutics|September 1, 1979
Forecasting individual pharmacokineticsL B Sheiner, S Beal, B Rosenberg, et al.
Journal of Pharmacokinetics and Biopharmaceutics|June 1, 1996
Do we need full compliance data for population pharmacokinetic analysis?P Girard, L B Sheiner, H Kastrissios, et al.
Journal of Pharmacokinetics and Biopharmaceutics|December 1, 1977
The clinical pharmacokinetics of phenytoinE Martin, T N Tozer, L B Sheiner, et al.
Journal of Pharmacokinetics and Biopharmaceutics|July 29, 1998
A semiparametric method for describing noisy population pharmacokinetic dataK Park, D Verotta, T F Blaschke, et al.
British Medical Journal|October 20, 1973
Pharmacokinetics of digoxin: interpreting bioavailabilityN Sanchez, L B Sheiner, H Halkin, et al.
Statistics in Medicine|November 20, 1998
A Markov mixed effect regression model for drug complianceP Girard, T F Blaschke, H Kastrissios, et al.
Journal of Pharmacokinetics and Pharmacodynamics|October 27, 2001
Selecting reliable pharmacokinetic data for explanatory analyses of clinical trials in the presence of possible noncomplianceJ Lu, J M Gries, D Verotta, et al.
Journal of Clinical Epidemiology|January 1, 1991
Laboratory data predicts survival post hospitalizationL B Sheiner, M J Easterling, B Mozes, et al.
Clinical Pharmacology and Therapeutics|March 1, 1974
Differences in serum digoxin concentrations between outpatients and inpatients: an effect of compliance?L B Sheiner, B Rosenberg, V V Marathe, et al.
Clinical Pharmacology and Therapeutics|January 1, 1976
The renal elimination of procainamideR L Galeazzi, L B Sheiner, T Lockwood, et al.
Pageof 15